In addition, antihypertensive drugs such as α-receptor blockers ... American College of Cardiology/American Heart Association classification of heart failure. ACE-I = Angiotensin converting ...

Nevada Heart & Vascular Center in Las Vegas recently treated the first patient in Nevada to undergo an innovative new ...

Lorundrostat effectively reduced 24-hour blood pressure in patients with well-treated, uncontrolled hypertension in the phase ...

A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people ...

CGRP antagonists are a new class of drugs designed to prevent migraine headaches by targeting a key molecule involved in pain transmission. Calcitonin gene-related peptide (CGRP) monoclonal ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, ...

The approval of the first-in-class drug comes from the phase 1/2 AUGMENT-101 study, in which treatment with Revuforj resulted in 21% of patients going into complete remission (CR) or complete ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster. The first-in-class dual ...